444
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Induction of Serum Amyloid A Genes Is Associated with Growth and Apoptosis of HC11 Mammary Epithelial Cells

, , , , , , , , , , , & show all
Pages 70-81 | Received 11 Jun 2007, Accepted 06 Sep 2007, Published online: 22 May 2014

  • 1) Walker, N. I., Bennett, R. E., and Kerr, J. F., Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185, 19–32 (1989).
  • 2) Quarrie, L. H., Addey, C. V., and Wilde, C. J., Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling. Cell Tissue Res., 281, 413–419 (1995).
  • 3) Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R. R., Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115, 49–58 (1992).
  • 4) Ha, S. H., Lee, S. R., Lee, T. H., Kim, Y. M., Baik, M. G., and Choi, Y. J., The expression of Bok is regulated by serum in HC11 mammary epithelial cells. Mol. Cells, 12, 368–371 (2001).
  • 5) Jung, D. J., Bong, J. J., and Baik, M., Extracellular proteinase inhibitor-accelerated apoptosis is associated with B cell activating factor in mammary epithelial cells. Exp. Cell Res., 292, 115–122 (2004).
  • 6) Lee, M., Hwang, I., Choi, Y., Paik, S., Lee, H. B., and Baik, M., EGF inhibits expression of WDNM1 and sulfated glycoprotein-2 genes in mammary epithelial cells. Biochem. Biophys. Res. Commun., 240, 104–107 (1997).
  • 7) Lee, M., Kim, H., Jeon, D., Hwang, I., Choi, B., Myung, K., Kim, H., Choi, Y., Paik, S., and Baik, M., Iron metabolism-related genes and mitochondrial genes are induced during involution of mouse mammary gland. Biochem. Biophys. Res. Commun., 224, 164–168 (1996).
  • 8) McAdam, K. P., Elin, R. J., Sipe, J. D., and Wolff, S. M., Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J. Clin. Invest., 61, 390–394 (1978).
  • 9) Whitehead, A. S., de Beer, M. C., Steel, D. M., Rits, M., Lelias, J. M., Lane, W. S., and de Beer, F. C., Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem., 267, 3862–3867 (1992).
  • 10) Meek, R. L., Urieli-Shoval, S., and Benditt, E. P., Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA, 91, 3186–3190 (1994).
  • 11) Urieli-Shoval, S., Cohen, P., Eisenberg, S., and Matzner, Y., Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium. J. Histochem. Cytochem., 46, 1377–1384 (1998).
  • 12) Urieli-Shoval, S., Meek, R. L., Hanson, R. H., Eriksen, N., and Benditt, E. P., Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am. J. Pathol., 145, 650–660 (1994).
  • 13) Benditt, E. P., and Meek, R. L., Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J. Exp. Med., 169, 1841–1846 (1989).
  • 14) Meek, R. L., and Benditt, E. P., Amyloid A gene family expression in different mouse tissues. J. Exp. Med., 164, 2006–2017 (1986).
  • 15) Meek, R. L., Eriksen, N., and Benditt, E. P., Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. USA, 89, 7949–7952 (1992).
  • 16) Ramadori, G., Sipe, J. D., and Colten, H. R., Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol., 135, 3645–3647 (1985).
  • 17) Brinckerhoff, C. E., Mitchell, T. I., Karmilowicz, M. J., Kluve-Beckerman, B., and Benson, M. D., Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science, 243, 655–657 (1989).
  • 18) Kisilevsky, R., and Subrahmanyan, L., Serum amyloid A changes high density lipoprotein’s cellular affinity: a clue to serum amyloid A’s principal function. Lab. Invest., 66, 778–785 (1992).
  • 19) Liang, J. S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., and Sipe, J. D., Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J. Lipid Res., 37, 2109–2116 (1996).
  • 20) Migita, K., Kawabe, Y., Tominaga, M., Origuchi, T., Aoyagi, T., and Eguchi, K., Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab. Invest., 78, 535–539 (1998).
  • 21) Mitchell, T. I., Jeffrey, J. J., Palmiter, R. D., and Brinckerhoff, C. E., The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim. Biophys. Acta, 1156, 245–254 (1993).
  • 22) Peristeris, P., Gaspar, A., Gros, P., Laurent, P., Bernon, H., and Bienvenu, J., Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture. Biochem. Cell Biol., 67, 365–370 (1989).
  • 23) Shainkin-Kestenbaum, R., Zimlichman, S., Lis, M., Lidor, C., Pomerantz, M., Knyszynski, A., Preciado-Patt, L., and Fridkin, M., Effect of serum amyloid A, an HDL-apolipoprotein, on endothelial cell proliferation: implication of an enigmatic protein in atherosclerosis. Biomed. Pept. Proteins Nucleic Acids, 2, 79–84 (1996).
  • 24) Steinmetz, A., Hocke, G., Saile, R., Puchois, P., and Fruchart, J. C., Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta, 1006, 173–178 (1989).
  • 25) Mantovani, A., The interplay between primary and secondary cytokines: cytokines involved in the regulation of monocyte recruitment. Drugs, 54 (Suppl 1), 15–23 (1997).
  • 26) Castell, J. V., Andus, T., Kunz, D., and Heinrich, P. C., Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Ann. NY Acad. Sci., 557, 87–99; discussion 100–101 (1989).
  • 27) You, S., Kim, H., El Halawani, M. E., and Foster, D. N., Three different turkey luteinizing hormone receptor (tLH-R) isoforms. II. Characterization of differentially regulated tLH-R messenger ribonucleic acid isoforms in the ovary. Biol. Reprod., 62, 117–124 (2000).
  • 28) You, S., Kim, H., Hsu, C. C., El Halawani, M. E., and Foster, D. N., Three different turkey luteinizing hormone receptor (tLH-R) isoforms. I. Characterization of alternatively spliced tLH-R isoforms and their regulated expression in diverse tissues. Biol. Reprod., 62, 108–116 (2000).
  • 29) Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., and Kalden, J. R., A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res., 22, 5506–5507 (1994).
  • 30) Meek, R. L., Eriksen, N., and Benditt, E. P., Serum amyloid A in the mouse: sites of uptake and mRNA expression. Am. J. Pathol., 135, 411–419 (1989).
  • 31) Inada, H., Izawa, I., Nishizawa, M., Fujita, E., Kiyono, T., Takahashi, T., Momoi, T., and Inagaki, M., Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol., 155, 415–426 (2001).
  • 32) Bouker, K. B., Skaar, T. C., Riggins, R. B., Harburger, D. S., Fernandez, D. R., Zwart, A., Wang, A., and Clarke, R., Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis, 26, 1527–1535 (2005).
  • 33) Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., and Hawkins, P. N., Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet, 358, 24–29 (2001).
  • 34) Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B., Bairey Merz, C. N., Sopko, G., Olson, M. B., and Reis, S. E., Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation, 109, 726–732 (2004).
  • 35) Uhlar, C. M., and Whitehead, A. S., Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem., 265, 501–523 (1999).
  • 36) Banner, D. W., D’Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H., and Lesslauer, W., Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell, 73, 431–445 (1993).
  • 37) Betts, J. C., Cheshire, J. K., Akira, S., Kishimoto, T., and Woo, P., The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem., 268, 25624–25631 (1993).
  • 38) Hagihara, K., Nishikawa, T., Sugamata, Y., Song, J., Isobe, T., Taga, T., and Yoshizaki, K., Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells, 10, 1051–1063 (2005).
  • 39) Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299–308 (1996).
  • 40) Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., and Leder, P., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity, 8, 297–303 (1998).
  • 41) Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V., and Mak, T. W., Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7, 715–725 (1997).
  • 42) Abbadie, C., Kabrun, N., Bouali, F., Smardova, J., Stehelin, D., Vandenbunder, B., and Enrietto, P. J., High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell, 75, 899–912 (1993).
  • 43) Thorn, C. F., and Whitehead, A. S., Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J. Immunol., 169, 399–406 (2002).
  • 44) Larson, M. A., Wei, S. H., Weber, A., Weber, A. T., and McDonald, T. L., Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem. Biophys. Res. Commun., 301, 1030–1037 (2003).
  • 45) Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr., TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784–787 (1996).
  • 46) Marti, A., Lazar, H., Ritter, P., and Jaggi, R., Transcription factor activities and gene expression during mouse mammary gland involution. J. Mammary Gland Biol. Neoplasia, 4, 145–152 (1999).
  • 47) Bing, Z., Huang, J. H., and Liao, W. S., NFkappa B interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription. J. Biol. Chem., 275, 31616–31623 (2000).
  • 48) Fleischman, D. A., and Gabrieli, J., Long-term memory in Alzheimer’s disease. Curr. Opin. Neurobiol., 9, 240–244 (1999).
  • 49) Boatright, K. M., and Salvesen, G. S., Mechanisms of caspase activation. Curr. Opin. Cell Biol., 15, 725–731 (2003).
  • 50) Strasser, A., O’Connor, L., and Dixit, V. M., Apoptosis signaling. Annu. Rev. Biochem., 69, 217–245 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.